Publications by authors named "Anna Lorena Chan"
Article Synopsis
- * A new treatment using a PEGylated compstatin derivative targeting C3 is in late-stage development to address geographic atrophy, an advanced form of AMD without approved therapies.
- * Research on the compstatin analog Cp40-KKK shows it remains effective in the eye for over three months post-injection, with significant presence and localization in retinal tissues, indicating its potential as a treatment option.
View Article and Find Full Text PDF